Keyphrases
Tumor Immunity
100%
DNA Vaccine
100%
HPV16
100%
Fusion Antigen
100%
Tumor
50%
Transgenic Mice
25%
Head-and-neck Cancer
25%
Vaccination
25%
Immunization
25%
Antitumor
25%
Fusion Gene
25%
Immunogen
25%
Cervical Cancer
25%
Immune Tolerance
25%
HPV16 E7
25%
Cellular Immunity
25%
Cellular Immune Response
25%
HPV6
25%
Up to Five
25%
Immune Rejection
25%
Therapeutic Study
25%
Prophylactic Administration
25%
% Protection
25%
Tumor-immune System
25%
Medicine and Dentistry
Human Papillomavirus Type 16
100%
DNA Immunization
100%
Cellular Immunity
50%
Tumor
50%
Head and Neck Cancer
25%
Infection
25%
Transgenic Mouse
25%
Neoplasm
25%
Immunological Tolerance
25%
Cervical Cancer
25%
Fusion Gene
25%
Immunology and Microbiology
Human Papillomavirus Type 16
100%
DNA Immunization
100%
Adoptive Immunity
50%
Immune Tolerance
25%
Neck
25%
Transgenic Mouse
25%
Fusion Gene
25%
Infection
25%